Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Monalizumab

Monalizumab is a novel immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A) . Monalizumab is a humanized monoclonal antibody against NKG2A that induces IFN-γ production, thereby activating natural killer cell function. Monalizumab has antitumor activity and can be used to study neck squamous cell carcinoma (HNSCC) .

Product Specifications

CAS Number

1228763-95-8

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Chk | IFNAR

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

NAGA Rabbit Polyclonal Antibody (Cy7)
orb1074220 100 µL

NAGA Rabbit Polyclonal Antibody (Cy7)

Sign In for Pricing
View Details
MAP4K1 Antibody
MBS9247950-01 0.05 mL

MAP4K1 Antibody

Sign In for Pricing
View Details
MAP4K1 Antibody
MBS9247950-02 0.2 mL

MAP4K1 Antibody

Sign In for Pricing
View Details
MAP4K1 Antibody
MBS9247950-03 5x 0.2 mL

MAP4K1 Antibody

Sign In for Pricing
View Details
SIGLEC-10 Antibody (RPE)
orb434839 100 Tests

SIGLEC-10 Antibody (RPE)

Sign In for Pricing
View Details
Lentiviral human LYPD1 shRNA (UAS) - Lentiviral human LYPD1 shRNA (UAS, RFP) (100)
GTR15109056 1 Vial

Lentiviral human LYPD1 shRNA (UAS) - Lentiviral human LYPD1 shRNA (UAS, RFP) (100)

Sign In for Pricing
View Details